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Abstract
Objective: The aim of this study was to describe the variation of soy product intake in
10 European countries by using a standardised reference dietary method. A subsidiary
aim was to characterise the pattern of soy consumption among a sub-group of
participants with a habitual health-conscious lifestyle (HHL), i.e. non-meat eaters who
are fish eaters, vegetarians and vegans.
Design: A 24-hour dietary recall interview (24-HDR) was conducted among a sample
(5–12%) of all cohorts ðn ¼ 36 900Þ in the European Prospective Investigation into
Cancer and Nutrition (EPIC). Study participants totalled 35 955 after exclusion of
subjects younger than 35 or older than 74 years of age. Soy products were subdivided
into seven sub-groups by similarity. Distribution of consumption and crude and
adjusted means of intake were computed per soy product group across countries.
Intake of soy products was also investigated among participants with an HHL.
Results: In total, 195 men and 486 women reported consuming soy products in the
24-HDR interview. Although soy product intake was generally low across all
countries, the highest intake level was observed in the UK, due to over-sampling of a
large number of participants with an HHL. The most frequently consumed soy foods
were dairy substitutes in the UK and France and beans and sprouts among mid-
European countries. For both genders, the sub-group of soy dairy substitutes was
consumed in the highest quantities (1.2 g day21 for men; 1.9 g day21 for women).
Participants with an HHL differed substantially from others with regard to
demographic, anthropometric and nutritional factors. They consumed higher
quantities of almost all soy product groups.
Conclusions: Consumption of soy products is low in centres in Western Europe. Soy
dairy substitutes are most frequently consumed. Participants with an HHL form a
distinct sub-group with higher consumptions of fruit, vegetables, legumes, cereals
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Many studies have suggested that soy has possible
beneficial effects on health, due to its phyto-oestrogen
content. Isoflavones, mostly genistein and daidzein, are
the most notable types of phyto-oestrogen occurring in
soy. Structurally they resemble endogenous oestrogen,
and have demonstrated both oestrogenic and anti-
oestrogenic properties, as well as antioxidative, anti-
proliferative and anti-angiogenic activities that are non-
hormonally dependent, in many in vitro and in vivo
studies1–6.
The information on current intake of soy and
isoflavones is limited, especially in Western populations.
Daily intake of isoflavones is estimated to be between 0.5
and 3 mg day21 in the USA7,8 and less than 1 mg day21 in
four countries in Europe9,10. Many Asian populations
consume 20–80 mg day21 of genistein, which is largely
derived from traditional soy foods. It has been reported
that Chinese women in Shanghai have a median intake of
100.6 g day21 for soy foods, 8.7 g day21 for soy protein and
39.6 mg day21 for isoflavones, as measured by a food-
frequency questionnaire11; thus the intake is 13 to 80 times
higher than in the USA, The Netherlands, Ireland, Italy or
the UK7–10.
Epidemiological studies suggest that consumption of a
diet rich in phyto-oestrogens, as seen in traditional Asian
societies, is associated with a lower risk of the so-called
Western diseases12–15 such as coronary heart disease16,17,
osteoporosis18–20, menopausal symptoms21 and hor-
mone-dependent cancers such as cancers of the breast,
ovary, prostate and colon12,13,22,23. Indeed, per capita
cereal and phyto-oestrogen consumptions show a
negative correlation with mortality rates for these cancers
between countries22,24.
The aim of this paper is to describe the variation in
consumption of soy products in the 10 European countries
participating in the European Prospective Investigation
into Cancer and Nutrition (EPIC), using a standardised
reference dietary method. A subsidiary aim is to
characterise and describe soy intake among subjects
who are non-meat eaters and who are leading a habitual
health-conscious lifestyle (HHL).
Methods and materials
The rationale of EPIC was to generate prospective, large-
scale data retrieved from populations that vary widely with
regard to both dietary patterns and cancer incidence, in
order to investigate diet–cancer associations25. The study,
which is based in 23 administrative centres in 10 Western
European countries (Denmark, France, Germany, Greece,
Italy, Norway, Spain, Sweden, The Netherlands and the
UK), involves 519 978 subjects, all of whom have provided
questionnaire data26.
Habitual dietary intake was assessed using country-
specific methods26. Therefore additional, standardised
24-hour diet recall interviews (24-HDR) were performed
among a sample of the study subjects and used as a
common calibration reference tool in order to adjust for
systematic over- or underestimation of individual baseline
dietary intake. Samples were selected randomly from each
cohort, weighted according to the cumulative numbers of
cancer cases expected over a 10-year follow-up period per
gender and 5-year age stratum. Thus, they represent
between 5% and 12% (1.5% in the UK) of the total EPIC
cohort in each participating country, and are referred to as
the EPIC calibration study population27–30 ðn ¼ 36 900Þ: A
detailed description of the rationale for the EPIC
calibration study, its design and the characteristics of the
study population are given elsewhere in this sup-
plement31. A software program (EPIC-SOFT) was devel-
oped for this purpose by the International Agency for
Research on Cancer in collaboration with all EPIC centres.
The structure and functions of EPIC-SOFT are described in
detail elsewhere32,33, as are the general concepts and
preliminary results34.
The soy product study is based on the EPIC calibration
study. The number of study participants following
exclusion of subjects younger than 35 or older than 74
years of age totalled 35 955 and included 13 031 (36.2%)
men and 22 924 (63.8%) women. In France, Norway,
Utrecht (The Netherlands) and Naples (Italy), only women
were recruited into EPIC.
All 24-HDR interviews included questions regarding
habitual diet and eating patterns and therefore enabled the
classification of participants as meat eaters or meat
avoiders. For the Oxford cohort only it was possible to
further characterise the meat avoiders as fish eaters,
vegetarians or vegans by using replies to a question
independent from the 24-HDR. Participants who habitu-
ally avoid consumption of meat were subsequently
defined as leading a habitual health-conscious lifestyle
(HHL). The calibration study population included 412
participants with an HHL, of whom 136 (33.0%) were men
and 276 (67.0%) were women. Two hundred and nineteen
(53.0%) of the participants with an HHL originated from
the UK, as this cohort selectively recruited a large number
of non-meat eaters to obtain a wide range of dietary
intake. Subsequently, the UK EPIC calibration population
was regrouped into two sub-groups unrelated to their
original geographical study centres (Cambridge and
Oxford): the cohort of subjects recruited from the general
population via general practitioners in both study centres,
which is referred to as the general population group ðn ¼
975Þ; and the ‘health-conscious’ group ðn ¼ 311Þ; which
was mainly recruited by post and included mostly subjects
with an HHL, but also 92 meat eaters who were excluded
from all further analyses concerning participants with an
HHL.
Various soy products were reported in the 24-HDRs
from each of the 10 countries participating. No standar-
dised food composition tables were available to estimate
the soy content of each soy product, so they were
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classified by similarity into seven product groups: (1)
beans and sprouts; (2) dairy substitutes (75% are liquid
items: milk, cream, drinks; and 25% are solid items:
cheese, yoghurt, desserts and ice creams); (3) grain
products (bread, pasta, flour, flakes); (4) meat substitutes
(soy schnitzels, hamburgers, frankfurters, soy balls and
mixed foods); (5) spreads and pastes; (6) traditional foods
(miso, tofu, tempeh); and (7) non-specified foods (when
reporters were unable to specify the type of soy food
consumed). The soy sauces and the soy oil and margarine
groups were excluded, as these products do not contain
isoflavones and their contribution to the total soy
consumption is rather low. All results are presented
separately for men and women. The distribution of soy
product consumption is described by country. In order to
describe the levels of soy food consumption across
countries, we examined the distribution curves and
computed the sample medians and the sample means
and their standard errors. Crude and adjusted means of
consumption (g day21) per soy sub-group across countries
were calculated on the basis of individual intake. Owing to
the low number of reporters of soy intake, crude and
adjusted means of consumption are presented by country
rather than centre, except for the two groups from the UK.
Crude means of consumption were adjusted for age by
using linear regression models. Adjusted means were
subsequently weighted according to recall season
(autumn, winter, spring and summer) and day of the
week, in order to compensate for day-to-day and seasonal
variations in diets. For this purpose, days of the week were
categorised into weekdays (Monday–Thursday) and
weekend days (Friday–Sunday). Results for soy product
consumption were similar when placing Friday in the
weekday category. Crude and adjusted means of intake for
those individuals reporting soy consumption in the 24-
HDR were also computed. Further adjustment for energy
intake did not alter the results substantially (,5% change)
and is not presented here.
A second aim of this study was to describe soy product
intake among the sub-group of participants with an HHL,
who were hypothesised to consume considerable
amounts of soy products. We describe characteristic
demographic, anthropometric and nutritional factors for
participants with an HHL and the other participants.
Computed crude and adjusted means of soy product
consumption among participants with an HHL across soy
product groups were computed as well.
All analyses were done using the SPSS 9.0 statistical
package for Windows35.
Results
Among the 35 955 calibration study participants (36% men
and 64% women), soy products were consumed on 1174
occasions by 681 participants, 342 (29%) of them occurring
among men and 832 (71%) among women.
Table 1 presents the distribution of consumption of soy
products among men and women. In total, 1.5% of males
and 2.1% of females reported soy consumption in the 24-
HDR. Among UK ‘health-conscious’ participants, approxi-
mately 35% of males and 24% of females reported
consumption of soy in the 24-HDR, compared with 1% of
males and 2% of females among the general population of
the UK.
Spain, Greece, Sweden, Denmark and Norway had the
lowest proportion of participants reporting soy consump-
tion for both genders (0.2–0.8%).
Of the seven soy product groups, soy dairy substitutes
were consumed the most frequently among both men and
women. However, there is a large variation between
countries: in The Netherlands, Germany and Spain, the
most frequently consumed soy food group among both
genders was beans and sprouts; in Italy, grain products; in
Denmark, soy meat substitutes; and in both populations of
the UK, soy dairy substitutes (Table 1). In most countries
(Italy, Spain, both populations of the UK, The Netherlands,
Germany and Denmark), males and females most
frequently consumed the same type of soy food groups.
Distribution curves of all soy food groups were skewed.
Medians for all sub-groups were zero for both genders.
Tables 2 and 3 present the crude and adjusted means of
soy product intake across countries for men and women,
respectively. Soy dairy substitutes were consumed in the
highest quantities among men and women, with adjusted
means of 1.2 and 1.9 g day21, respectively. Men and
women of the UK ‘health-conscious’ group consumed the
highest quantities of soy dairy substitutes (149 and
112 g day21, respectively), soy meat substitutes (15.9 and
4.7 g day21, respectively), soy traditional foods (8.5 and
5.3 g day21, respectively) and non-specific soy foods (22.3
and 14.4 g day21, respectively). However, intake levels for
the UK general population were substantially lower; mean
intake of soy dairy substitutes was 0.7 and 5.3 g day21 for
men and women, respectively, and mean intake of soy
meat substitutes was 0.4 and 0.2 g day21 for men and
women, respectively.
Among the 681 participants reporting soy intake in the
24-HDR interview, the highest intakes were reported for
soy dairy substitutes (62.6 and 32.8 g day21 for men and
women, respectively), while soy grain products were
consumed in the lowest quantities among men
(2.8 g day21) and soy pastes and spreads among women
(0.3 g day21) (Tables 2 and 3).
Table 4 presents the general characteristics of the sub-
group of participants with an HHL and the rest of the
cohort. Four hundred and twelve subjects were following
an HHL, of which 136 (33.0%) were men and 276 (67.0%)
were women. As indicated before, due to the over-
sampling of non-meat eaters in the UK ‘health-conscious’
group, 71% of men and 50% of women with an HHL
originated from the UK.
Men and women with an HHL were more educated,
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younger, taller, had a lower body mass index (BMI) and
were less likely to be current smokers than the others
(Table 4). Mean total energy intake (kcal day21) was lower
for men with an HHL, but not for women. Both men and
women with an HHL consumed a lower percentage of
their daily energy intake as protein and fat and a higher
percentage of their daily energy intake as carbohydrates
than the rest of the cohort. Participants with an HHL also
had higher intakes of fruit, vegetables, legumes, cereals
and cereal products and non-alcoholic beverages, and
lower intakes of dairy products, eggs and egg products,
fish and shellfish and alcoholic beverages, than the rest of
the cohort (Table 4).
Table 5 presents the crude and adjusted means of soy
product intake among participants with an HHL and the
rest of the cohort. Male participants with an HHL did not
consume soy beans and sprouts, and consumed a
considerably smaller quantity of soy grain products than
the others, but they did consume considerably higher
amounts of all other soy product groups compared with
the rest of the cohort (excluding non-specific soy foods).
In particular, the intake of soy dairy substitutes was high,
with a mean intake of 106.5 g day21 among male
participants with an HHL compared with 0.3 g day21
among the rest of the cohort (Table 5).
Women with an HHL consumed all soy product groups
in larger amounts than the rest of the cohort (excluding
non-specific soy foods). As for men, the highest intake of
soy among women with an HHL was for dairy substitutes
(70.8 g day21 compared with 1.2 g day21 for the rest of the
cohort). The lowest intake of soy products among women
with an HHL was for soy grain products (0.2 g day21)
(Table 5).
Discussion
Soy foods have been a staple part of the Chinese diet for
more than 4000 years but have only become more popular
in Western countries over the last few decades. The results
of this study indicate a low, but variable intake of soy
products across Western European countries.
Soy intake varied across Europe, with the most common
Table 1 Distribution of soy product consumption among the European Prospective Investigation
into Cancer and Nutrition (EPIC) calibration study population: men and women
Country (n )
Number of individuals reporting
soy consumption (% of total)
Soy product group consumed
most frequently
Greece
M (1312) 5 (0.4) Soy meat substitutes
F (1374) 11 (0.8) Soy dairy substitutes
Spain
M (1777) 7 (0.4) Soy beans and sprouts
F (1443) 6 (0.4) Soy beans and sprouts
Italy
M (1444) 24 (1.7) Soy beans and sprouts, soy grain products
F (2512) 52 (2.1) Soy grain products
France
M (0) NA –
F (4639) 150 (3.2) Soy dairy substitutes
Germany
M (2268) 33 (1.5) Soy beans and sprouts
F (2150) 37 (1.7) Soy beans and sprouts
The Netherlands
M (1024) 61 (6.0) Soy beans and sprouts
F (2960) 125 (4.2) Soy beans and sprouts
UK, general population
M (404) 3 (0.7) Soy dairy substitutes
F (571) 11 (1.9) Soy dairy substitutes
UK, ‘health-conscious’
M (114) 40 (35.1) Soy dairy substitutes
F (197) 47 (23.8) Soy dairy substitutes
Denmark
M (1923) 12 (0.6) Soy meat substitutes
F (1995) 21 (1.1) Soy meat substitutes
Sweden
M (2765) 10 (0.4) Soy grain products
F (3285) 23 (0.7) Soy dairy substitutes
Norway
M (0) NA –
F (1798) 4 (0.2) Soy dairy substitutes
Total
M (13 031) 195 (1.5) Soy dairy substitutes
F (22 924) 486 (2.1) Soy dairy substitutes
Total: M+F (35 955) 681 (1.9) Soy dairy substitutes
M – male; F – female; NA – not available.
L Keinan-Boker et al.1220
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soy products being beans and sprouts, grain products and
dairy substitutes in Mediterranean countries (Spain,
France, Italy and Greece). Soy beans and sprouts are the
most commonly consumed soy products in mid-European
countries (The Netherlands and Germany), while soy meat
substitutes are most frequently consumed in Denmark.
Soy dairy substitutes are most commonly consumed in
France and the UK.
Quantification of direct soy intake in our study
population was not feasible, as we had no valid data
regarding the soy content of each relevant food item
across participating countries. However, this study
suggests that the consumption of all soy products is low
across Europe, at least among those not following a
health-conscious diet. Dietary recall questionnaires have
been used to estimate the intake of isoflavones among
Japanese36 and Korean37 subjects, by applying a phyto-
oestrogen value found in the literature per soy item
studied. Using this approach, median intakes have been
reported to be between 9 and 12 mg day21 for daidzein
and 15 and 20 mg day21 for genistein in Japan36, and total
isoflavone intake has been estimated to be about
Table 5 Consumption of soy products in g day21 by participants with a habitual health-conscious lifestyle (HHL), compared with other
subjects
Men Women
Soy product groups* Mean
Participants
with an HHL (n ¼ 136)
Rest of the cohort
(n ¼ 12 895)
Participants
with an HHL (n ¼ 276)
Rest of the cohort
(n ¼ 22 648)
1. Beans and sprouts Crude (SE) – 0.11 (0.01) 0.54 (0.31) 0.20 (0.03)
Adjusted† (SE) 0.11 (0.01) 0.67 (0.38) 0.21 (0.03)
2. Dairy substitutes Crude (SE) 77.34 (11.83) 0.32 (0.09) 57.42 (8.67) 1.13 (0.13)
Adjusted† (SE) 106.50 (16.18) 0.34 (0.10) 70.80 (10.70) 1.21 (0.14)
3. Grain products Crude (SE) ,0.01 (,0.01) 0.05 (0.03) 0.16 (0.16) 0.10 (0.02)
Adjusted† (SE) ,0.01 (0.01) 0.05 (0.03) 0.20 (0.20) 0.10 (0.02)
4. Meat substitutes Crude (SE) 8.84 (2.77) 0.17 (0.05) 4.44 (1.26) 0.11 (0.02)
Adjusted† (SE) 12.17 (3.83) 0.18 5.47 (1.55) 0.12 (0.029)
5. Soy pastes Crude (SE) 1.06 (0.67) 0.07 (0.03) 0.25 (0.14) 0.01 (,0.01)
Adjusted† (SE) 1.46 (0.92) 0.08 0.31 (0.17) 0.01 (0.01)
6. Traditional foods Crude (SE) 5.62 (2.07) 0.04 (0.02) 2.65 (0.87) 0.06 (0.02)
Adjusted† (SE) 7.75 (2.86) 0.05 3.30 (2.79) 0.06 (0.02)
7. Non-specified Crude (SE) 11.56 (4.01) ,0.01 (,0.01) 6.84 (2.26) ,0.01 (,0.01)
Adjusted† (SE) 15.92 (5.55) ,0.01 8.46 ,0.01 (,0.01)
SE – standard error.
* Soy product groups: 1 – soy beans and sprouts; 2 – soy milk, drinks and dairy substitutes (including cheese, yoghurts, desserts and ice creams); 3 – soy
grain products (including bread, pasta, flour, flakes); 4 – soy meat substitutes (soy hamburgers, frankfurters, balls and schnitzels as well as mixed foods); 5
– soy pastes and spreads; 6 – traditional soy foods (tofu, tempeh, miso); 7 – non-specified soy foods.
† Adjusted for age and weighted according to day and season of recall.











n 136 12 895 276 22 648
Current smokers (%) 13.4 27.9 8.1 18.5
Academic education (%) 49.3 21.4 41.7 20.9
Mean age in years (SD) 54.6 (7.4) 56.8 (8.0) 52.9 (8.2) 55.3 (8.0)
Mean height in cm (SD) 177.1 (7.1) 174.2 (7.4) 164.2 (6.2) 162.3 (6.6)
Mean weight in kg (SD) 73.4 (9.9) 81.8 (11.8) 62.6 (10.4) 67.0 (11.7)
Mean BMI in kg m22 (SD) 23.4 (2.9) 27.0 (3.5) 23.2 (4.0) 25.5 (4.4)
Mean energy intake in kcal day21 (SD) 2216.0 (762.7) 2533.3 (872.0) 1888.1 (679.1) 1874.7 (637.2)
% of daily energy from carbohydrate (%) 52.2 42.2 51.2 45.2
% of daily energy from protein (%) 11.8 14.7 12.2 15.5
% of daily energy from fat (%) 34.2 37.1 34.7 36.4
Mean intake of fruit in g day21 (SD) 282.3 (264.1) 220.4 (251.6) 284.5 (240.6) 226.4 (215.2)
Mean intake of vegetables in g day21 (SD) 249.9 (200.4) 169.5 (162.1) 235.4 (172.9) 167.9 (149.2)
Mean intake of legumes in g day21 (SD) 34.0 (108.7) 14.5 (57.4) 15.3 (46.1) 7.1 (34.1)
Mean intake of dairy products in g day21 (SD) 196.8 (264.7) 298.6 (289.1) 244.5 (307.3) 289.1 (241.6)
Mean intake of eggs and egg products in g day21 (SD) 7.3 (21.4) 17.4 (35.7) 5.4 (16.0) 13.7 (29.0)
Mean intake of cereals and cereal products in g day21 (SD) 283.6 (203.0) 246.8 (172.7) 199.9 (139.2) 170.3 (118.6)
Mean intake of fish and shellfish in g day21 (SD) 7.6 (37.8) 42.9 (86.4) 13.3 (40.4) 31.2 (64.7)
Mean intake of non-alcoholic beverages in g day21 (SD) 1585.2 (852.4) 1320.9 (866.3) 1665.5 (864.9) 1435.6 (832.2)
Mean intake of alcoholic beverages in g day21 (SD) 204.0 (438.5) 366.1 (510.7) 89.6 (196.7) 117.6 (211.2)
SD – standard deviation; BMI – body mass index.
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15 mg day21 in Korea37 and about 40 mg day21 in China11.
In our study, daily intakes of isoflavones were estimated
based on isoflavone values of soy foods, listed in Table 638,
which have been published in the literature. Excluding
participants from the UK ‘health-conscious’ group, mean
estimates for daily isoflavone intake for both genders were
lower than 2.0 mg day21. These estimates are in line with
previously published data concerning Western popu-
lations7–10.
Not only are the quantities of intake of soy products
among Western subjects substantially lower than among
Asian subjects, the sources of soy foods differ as well. Our
findings indicate that soy dairy substitutes are the soy
foods most frequently consumed and in the highest
quantities, while traditional soy products are being
consumed at less than 1 g day21. This is in stark contrast
with Japanese, Chinese and Korean individuals, whose
estimated intake of traditional soy products has been
reported to be about 100 g daily11,36,37,39,40. Such a low
level of consumption may complicate the detection of
significant associations between exposure and end results
in future analytical studies. However, significant associ-
ations between isoflavone dietary intake and risk for
prostate cancer41 or chronic heart diseases42 were
reported previously in Caucasian populations consuming
a Western diet, with a low intake of soy. Low as it is, the
soy intake in the calibration study population might be
underestimated, as soy protein has long been utilised in
food systems (whole soybeans processed into snack
foods, beverages and fermented foods; soy flour and grits
blended into corn, wheat or sorghum and used in cereal
mixtures or baked goods; soy proteins used in processed
meat products or added to soup stock cubes and
doughnuts). Obviously, exposure to unsuspected and
hidden sources of soy is generally unaccounted for43–45.
For UK ‘health-conscious’ participants and participants
with an HHL, the mean consumption of almost all soy
product groups was substantially higher than for the rest of
the cohort and the estimated daily isoflavone intake was in
the range of 15–30 mg day21, comparable with levels of
consumption in Asian diets11,37,38. These estimates have
been confirmed by Verkasalo et al.46, who showed that
high soy consumers in EPIC–Oxford had average
isoflavone intakes and serum isoflavone concentrations
similar to those of Asian populations. This means that
although soy dairy substitutes and soy meat substitutes
contain smaller quantities of isoflavones than traditional
soy foods such as tofu, miso and natto per 100 g of edible
food item (Table 6)38, the total daily intake of isoflavones
may be comparable. This is most likely due to different
portion sizes and a higher frequency of consumption of
soy dairy substitutes than traditional soy products.
In addition to a higher soy intake among participants
with an HHL, this sub-group also differed from the other
participants with regard to age and certain anthropometric
(mean BMI), nutritional (percentage of energy produced
from carbohydrates) and dietary (intakes of fruit,
vegetables, cereals and legumes) factors, which is
consistent with other data on vegetarians and vegans47–50.
Thus, a high consumption of soy products among Western
subjectsmaybeamarkerof ahealthier habitual lifestyle. This
sub-group could therefore serve as a reference group in
future analytical studies in which various hypotheses on the
association between the intake of certain food groups (i.e.
meat or isoflavones) and diseases might be tested.
This study is the first to describe the consumption of soy
products in Western Europe, in which soy intake is based
mostly on easily accessible and ready-to-eat products, and
thus different from traditional soy products consumed by
Asian populations. Its main advantage is the coverage of a
variety of national, geographical and cultural regions.
However, in order to evaluate the study findings, one
should consider several methodological issues. Although
the study population is sampled from, and representative
of, the different EPIC cohorts, it is not, in itself, a
representative sample on the national level. In addition,
lack of standardisation of the different soy items across the
participating countries (soy content, ingredients) has
limited our ability to estimate direct soy and isoflavone
intakes. It may be argued that use of the 24-HDR is prone
to day-to-day variations in food intake, especially when
less frequently consumed foods, such as soy, are
concerned. This would have created a problem if we
were to describe individual habitual daily intake of soy.
However, we aimed to describe the variability of soy
intake between countries. As the calibration study
included a random sample of each of the EPIC cohorts
and as the sampling procedures were distributed on all
seasons and days of the week31, it is reasonable to expect
Table 6 Mean levels of isoflavones in selected food items,
expressed in mg/100 g of edible portion38
Food item Total isoflavones*
Beans and sprouts
Soy beans 84.0 (13.8–153.4)
Soy dairy substitutes
Soy milk 9.6 (1.26–21.1)
Soy cheese (unspecified) 31.3 (3.33–21.1)
Cheddar 7.1 (3.40–10.9)
Mozzarella 7.7 (based on one sample)
Parmesan 6.4 (based on one sample)
Soy yoghurt 16.3 (based on one sample)
Soy meat substitutes









Natto (boiled and fermented
soybeans)
58.9 (46.4–87.0)
* Genistein, daidzein, glycetin.
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that the population mean will not be influenced by day-to-
day variability of individual intake. A question may arise
regarding the appropriateness of using the population
mean, not its median, when distribution curves are
skewed. Indeed, geometric means or medians are some-
times preferred to the means when one plans to report
statistical tests or, perhaps, when there is a special interest
in the centre of a distribution, i.e. when focus is on the so-
called typical individual in a population. However, the
property that the sample mean is an unbiased estimator of
the population mean, regardless of the underlying
distribution of the variable, justifies the use of a mean
when the aim is focused on population, not individual,
intake, as is the case in this study.
An additional point refers to the range of intake; Asian
populations generally present with uniformly high soy
consumption, while intake in Western populations is
obviously uniformly low (except for the sub-group of non-
meat eaters). The uniform range of consumption levels,
either in the high or the low soy-consuming societies, may
mask possible associations between exposure and
endpoints.
As soy intake is currently being studied world-wide with
regard to its possible associations with many chronic
diseases, improvement of the information on soy intake in
Europe is of great importance. Likewise, use of
populations with a wide range of soy consumption for
analytical studies may prove to be more informative and
useful.
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